This contract involves the supply of exclusive Cyramza medications from Lilly for the Fuenlabrada University Hospital. The total value of the contract is €106,375. Suppliers are invited to provide these specific medications, which are essential for patient care in the health sector. The awarded supp
Contract awarded. Originally published 8 months ago.
No single supplier dominates the field.
In healthcare medical, PUBLIC ENTITY UNIVERSITY HOSPITAL OF FUENLABRA has awarded 5 contracts to 5 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
The Hospital Universitario de Fuenlabrada is seeking suppliers for laboratory materials, including reagents, controls, calibrators, and specific consumables. Additionally, suppliers must provide the necessary equipment for conducting autoimmunity determinations in the hospital's laboratory. This con
The Hospital Universitario de Fuenlabrada is seeking suppliers for the provision of a specific radiopharmaceutical, Lutathera® (with active ingredient [177-LU]-DOTA0-TYR3-OCTREOTATO), in a concentration of 370 MBq/mL for infusion. This contract is valued at approximately €279,936 and is part of the
The Hospital Universitario de Fuenlabrada is seeking suppliers for the provision of implantable, radiopaque artificial urinary sphincters specifically designed for male patients. This contract is valued at €170,000 and is part of the health sector. The awarded supplier for this contract is Productos
Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.
Cardiff and Vale University Health Board is seeking qualified providers to deliver outsourced orthopaedic surgical procedures through a competitive mini-competition process.
St George's University Hospitals NHS Foundation Trust is seeking a supplier to provide comprehensive Non-Invasive Prenatal Testing services, including equipment, reagents, software, and maintenance for approximately 5,000 annual patient tests, with a contract starting March/April 2027 and an initial 2-year term with optional extensions.
Opportunity to provide outsourced ADHD and ASD assessment and diagnostic evaluation services.
